Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II study von Scinto, A F, Ferraresi, V, Milella, M, Tucci, E, Santomaggio, C, Pasquali-Lasagni, R, Vecchio, M R Del, Campioni, N, Nardi, M, Cognetti, F

Volltext

Carboplating(C) and vinorelbine(V) in metastatic(M) non small cell lung cancer(NSCLC). Preliminary results : C. Santomaggio, R. Righi; bE. Tucci, F. Pepi; R. Algeri, A. Andrei. Pneumology Dept, Florence; bRadiotherapy Dept, University, Siena; Medicine I Dept, Grosseto. Italy

Volltext

Phase II randomised trial: Gemcitabine (GEM) + Vinorelbine (VNB) vs Gemcitabine + Vindesine (VDS) in Stage IIIB/IV -NSCLC- Elderly patients (pts). Italian Association of Hospital P... von Santomaggio, C, Portalone, L, De Marinis, F, Coppolino, S

Volltext

Phase II study of carboplatin + etoposide + epirubicin (CEE) in small cell lung cancer von Santomaggio, C., Di Vincenzo, M., Labardi, C., Lopes Pegna, A., Nutini, S., Righi, R., Romagnoli, E.

Volltext

Carboplatin and vinorelbine in the treatment of advanced non-small-cell lung cancer : A multicenter phase II study von SANTOMAGGIO, C, TUCCI, E, RINALDINI, M, ALGERI, R, RIGHI, R, PEPI, F, GHEZZI, P, ANDREI, A, BELLEZZA, A

Volltext

53 P - Ifosfamide, cisplatin and etoposide (ICE) combination in locally advanced non small cell lung cancer (NSCLC): a phase II study von Scinto, A.F., Milella, M., Rendina, E.A., Tonachella, R., Nardi, M., Tucci, E., Santomaggio, C., Ferraresi, V., Pasquali Lasagni, R., Del Vecchio, M.R., Cognetti, F.

Volltext

The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: A prospective single-center study von Baldazzi, Valentina, M.D, Tassi, Renato, M.D, Lapini, Alberto, M.D, Santomaggio, Carmine, M.D, Carini, Marco, M.D, Mazzanti, Roberto, M.D

Volltext

Vinorelbine in Non-Small Cell Lung Cancer: Real-World Data From a Single-Institution Experience von Nobili, Stefania, Lavacchi, Daniele, Perrone, Gabriele, Vicini, Giulio, Tassi, Renato, Landini, Ida, Grosso, AnnaMaria, Roviello, Giandomenico, Mazzanti, Roberto, Santomaggio, Carmine, Mini, Enrico

Volltext

"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II st... von Bruera, Gemma, Santomaggio, Alessandra, Cannita, Katia, Baldi, Paola Lanfiuti, Tudini, Marianna, De Galitiis, Federica, Mancini, Maria, Marchetti, Paolo, Antonucci, Adelmo, Ficorella, Corrado, Ricevuto, Enrico

Volltext

Triplet schedule of weekly 5-Fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: A dose-finding and phase II study von MORELLI, M. F, SANTOMAGGIO, A, GUGLIELMI, F, MARTELLA, F, LANFIUTI BALDI, P, PORZIO, G, RUSSO, A, GEBBIA, N, IACOBELLI, S, MARCHETTI, P, FICORELLA, C, RICEVUTO, E, CANNITA, K, DE GALITIIS, F, TUDINI, M, BRUERA, G, MANCINI, M, PELLICCIONE, M, CALISTA, F

Volltext

Effectiveness of FIr-B/FOx and liver metastasectomies in liver-only metastatic colorectal cancer (MCRC) von Bruera, G., Cannita, K., Lanfiuti Baldi, P., Santomaggio, A., Marchetti, P., Nuzzo, G., Antonucci, A., Ficorella, C., Ricevuto, E.

Volltext

Massive intrathoracic lipoma in men1 syndrome von Sturiale, Alessandro, Giudici, Francesco, Alemanno, Giovanni, Cavalli, Tiziana, Addasi, Rami, Santomaggio, Carmine, Meoni, Giulia, Brandi, Maria Luisa, Tonelli, Francesco

Volltext

Clinical properness of poker schedule weekly alternating 5-fluorouracil, irinotecan, bevacizumab, and oxaliplatin (FIr-B/FOx) in young-elderly metastatic colorectal cancer (MCRC) von Bruera, G., Santomaggio, A., Cannita, K., Lanfiuti Baldi, P., Tudini, M., De Galitiis, F., Marchetti, P., Antonucci, A., Ficorella, C., Ricevuto, E.

Volltext

“Poker” schedule of weekly alternating 5-fluorouracil, irinotecan, bevacizumab, and oxaliplatin (FIR-B/FOX) in advanced colorectal cancer: A phase II study von Santomaggio, A., Ricevuto, E., Cannita, K., Bruera, G., Tudini, M., Lanfiuti Baldi, P., Mancini, M., Porzio, G., Marchetti, P., Ficorella, C.

Volltext

Modulation of GemOx chemotherapy according to CIRS in elderly patients with advanced pancreatic cancer von TUDINI, Marianna, PALLUZZI, Eleonora, CANNITA, Katia, MANCINI, Maria, SANTOMAGGIO, Alessandra, BRUERA, Gemma, LANFIUTI BALDI, Paola, PELLICCIONE, Michela, RICEVUTO, Enrico, FICORELLA, Corrado

Volltext

The safety of dose-dense liposomal-encapsulated doxorubicin in association with docetaxel (MyTax) in breast cancer von Mancini, M, Cannita, K, Santomaggio, A, Tudini, M, De Galitiis, F, Morelli, M, Rispoli, A, Martella, F, Porzio, G, Pelliccione, M, Cocciolone, V, Lanfiuti Baldi, P, Penco, M, Romano, S, Fratini, S, Stifani, G, Marchetti, P, Ficorella, C, Ricevuto, E

Volltext

"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin von Ficorella, Corrado, Bruera, Gemma, Marchetti, Paolo, Santomaggio, Alessandra, De Galitiis, Federica, Antonucci, Adelmo, Cannita, Katia, Ricevuto, Enrico, Mancini, Maria, Baldi, Paola Lanfiuti, Tudini, Marianna

Volltext

Limited-Stage Small-Cell Lung Cancer Treated with Early Chemo-Radiotherapy: The Impact of Effective Chemotherapy von Scotti, Vieri, Meattini, Icro, Saieva, Calogero, Rampini, Andrea, De Luca Cardillo, Carla, Bastiani, Paolo, Mangoni, Monica, Agresti, Benedetta, Santomaggio, Carmine, Di Cataldo, Vanessa, Franzese, Ciro, Livi, Lorenzo, Magrini, Stefano Maria, Biti, Giampaolo

Volltext

Timed-Flat Infusion of 5-Fluorouracil Associated with Docetaxel as First-Line Treatment of Patients with Metastatic Breast Cancer von Rispoli, Anna Iolanda, Morelli, Maria Francesca, Ricevuto, Enrico, Cannita, Katia, Santomaggio, Alessandra, Mancini, Maria, Tudini, Marianna, Cianci, Giovanni, Porzio, Giampiero, Lanfiuti Baldi, Paola, Di Rocco, Christiana Zorica, Tinari, Nicola, Iacobelli, Stefano, Marchetti, Paolo, Ficorella, Corrado

Volltext

The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: A biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? von Bruera, Gemma, Cannita, Katia, Tessitore, Alessandra, Russo, Antonio, Alesse, Edoardo, Ficorella, Corrado, Ricevuto, Enrico

Volltext